002422 科倫藥業
按盤價 
33.450 +1.950 (+6.190%)
33.450 +1.950 (+6.190%) | 2025/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 13,276,730 | -20.92% | 21,812,414 | 21,453,929 | 19,038,216 | 17,277,408 | |
| 減：營業總成本 | 11,864,487 | -11.56% | 17,850,874 | 18,277,363 | 17,223,484 | 16,290,481 | |
| 其中:營業成本 | 6,918,963 | -13.22% | 10,536,821 | 10,205,535 | 9,040,158 | 7,660,152 | |
| 財務費用 | 46,401 | -14.87% | 66,179 | 233,761 | 479,834 | 505,647 | |
| 資產減值損失 | (66,882) | 119.29% | (130,590) | (130,551) | (44,113) | (50,428) | |
| 公允價值變動收益 | 21,419 | 56.61% | 19,898 | 14,666 | 9,861 | 4,828 | |
| 投資收益 | 177,597 | -38.39% | 345,018 | 358,882 | 234,580 | 214,829 | |
| 其中：對聯營企業和合營企業的投資收益 | 158,955 | -41.81% | 320,466 | 352,105 | 228,194 | 127,303 | |
| 營業利潤 | 1,779,909 | -53.28% | 4,426,321 | 3,654,143 | 2,195,142 | 1,319,843 | |
| 利潤總額 | 1,648,930 | -55.50% | 4,285,359 | 3,580,426 | 2,067,919 | 1,177,616 | |
| 減：所得稅費用 | 404,160 | -48.49% | 923,404 | 933,787 | 363,697 | 309,499 | |
| 淨利潤 | 1,244,771 | -57.39% | 3,361,954 | 2,646,639 | 1,704,221 | 868,117 | |
| 減：非控股權益 | 44,105 | -90.20% | 426,062 | 190,527 | (1,103) | (234,438) | |
| 股東淨利潤 | 1,200,666 | -51.41% | 2,935,892 | 2,456,112 | 1,705,324 | 1,102,554 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.750 | -52.23% | 1.860 | 1.690 | 1.220 | 0.780 | |
| 每股派息 (元) * | 0.126 | -51.54% | 0.763 | 0.800 | 0.616 | 0.426 | |
| 每股淨資產 (元) * | 14.835 | 5.34% | 14.037 | 13.009 | 10.864 | 9.721 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 08/01/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
